vs
FIGS, Inc.(FIGS)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
FIGS, Inc.的季度营收约是REPLIGEN CORP的1.0倍($201.9M vs $197.9M),FIGS, Inc.净利率更高(9.2% vs 6.7%,领先2.5%),FIGS, Inc.同比增速更快(33.0% vs 13.6%),FIGS, Inc.自由现金流更多($58.1M vs $17.6M),过去两年FIGS, Inc.的营收复合增速更高(30.1% vs 14.4%)
FIGS是一家总部位于美国加利福尼亚州圣莫尼卡的服饰企业,由希瑟·哈森与特里娜·斯皮尔于2013年共同创立,二人目前共同担任首席执行官。品牌专注为医疗从业者提供医用刷手服及相关专业产品,是医疗工装领域的知名品牌。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
FIGS vs RGEN — 直观对比
营收规模更大
FIGS
是对方的1.0倍
$197.9M
营收增速更快
FIGS
高出19.3%
13.6%
净利率更高
FIGS
高出2.5%
6.7%
自由现金流更多
FIGS
多$40.5M
$17.6M
两年增速更快
FIGS
近两年复合增速
14.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $201.9M | $197.9M |
| 净利润 | $18.5M | $13.3M |
| 毛利率 | 62.9% | 52.5% |
| 营业利润率 | 9.3% | 9.0% |
| 净利率 | 9.2% | 6.7% |
| 营收同比 | 33.0% | 13.6% |
| 净利润同比 | 881.8% | 143.9% |
| 每股收益(稀释后) | $0.10 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FIGS
RGEN
| Q4 25 | $201.9M | $197.9M | ||
| Q3 25 | $151.7M | $188.8M | ||
| Q2 25 | $152.6M | $182.4M | ||
| Q1 25 | $124.9M | $169.2M | ||
| Q4 24 | $151.8M | $174.1M | ||
| Q3 24 | $140.2M | $154.9M | ||
| Q2 24 | $144.2M | $154.1M | ||
| Q1 24 | $119.3M | $151.3M |
净利润
FIGS
RGEN
| Q4 25 | $18.5M | $13.3M | ||
| Q3 25 | $8.7M | $14.9M | ||
| Q2 25 | $7.1M | $14.9M | ||
| Q1 25 | $-102.0K | $5.8M | ||
| Q4 24 | $1.9M | $-30.3M | ||
| Q3 24 | $-1.7M | $-654.0K | ||
| Q2 24 | $1.1M | $3.3M | ||
| Q1 24 | $1.4M | $2.1M |
毛利率
FIGS
RGEN
| Q4 25 | 62.9% | 52.5% | ||
| Q3 25 | 69.9% | 53.2% | ||
| Q2 25 | 67.0% | 50.0% | ||
| Q1 25 | 67.6% | 53.6% | ||
| Q4 24 | 67.3% | 26.1% | ||
| Q3 24 | 67.1% | 50.0% | ||
| Q2 24 | 67.4% | 49.8% | ||
| Q1 24 | 68.9% | 49.5% |
营业利润率
FIGS
RGEN
| Q4 25 | 9.3% | 9.0% | ||
| Q3 25 | 6.4% | 8.9% | ||
| Q2 25 | 6.5% | 7.6% | ||
| Q1 25 | -0.2% | 3.9% | ||
| Q4 24 | 5.9% | -17.7% | ||
| Q3 24 | -6.2% | -5.1% | ||
| Q2 24 | 1.1% | 1.0% | ||
| Q1 24 | 0.4% | 1.3% |
净利率
FIGS
RGEN
| Q4 25 | 9.2% | 6.7% | ||
| Q3 25 | 5.8% | 7.9% | ||
| Q2 25 | 4.7% | 8.2% | ||
| Q1 25 | -0.1% | 3.4% | ||
| Q4 24 | 1.2% | -17.4% | ||
| Q3 24 | -1.2% | -0.4% | ||
| Q2 24 | 0.8% | 2.2% | ||
| Q1 24 | 1.2% | 1.4% |
每股收益(稀释后)
FIGS
RGEN
| Q4 25 | $0.10 | $0.24 | ||
| Q3 25 | $0.05 | $0.26 | ||
| Q2 25 | $0.04 | $0.26 | ||
| Q1 25 | $0.00 | $0.10 | ||
| Q4 24 | $0.01 | $-0.55 | ||
| Q3 24 | $-0.01 | $-0.01 | ||
| Q2 24 | $0.01 | $0.06 | ||
| Q1 24 | $0.01 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $437.5M | $2.1B |
| 总资产 | $580.0M | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
FIGS
RGEN
| Q4 25 | $82.0M | $767.6M | ||
| Q3 25 | $46.5M | $748.7M | ||
| Q2 25 | $50.8M | $708.9M | ||
| Q1 25 | $90.0M | $697.2M | ||
| Q4 24 | $85.6M | $757.4M | ||
| Q3 24 | $124.1M | $784.0M | ||
| Q2 24 | $131.8M | $809.1M | ||
| Q1 24 | $155.3M | $780.6M |
总债务
FIGS
RGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益
FIGS
RGEN
| Q4 25 | $437.5M | $2.1B | ||
| Q3 25 | $413.3M | $2.1B | ||
| Q2 25 | $396.5M | $2.1B | ||
| Q1 25 | $381.5M | $2.0B | ||
| Q4 24 | $377.1M | $2.0B | ||
| Q3 24 | $403.5M | $2.0B | ||
| Q2 24 | $401.7M | $2.0B | ||
| Q1 24 | $389.9M | $2.0B |
总资产
FIGS
RGEN
| Q4 25 | $580.0M | $2.9B | ||
| Q3 25 | $544.7M | $2.9B | ||
| Q2 25 | $517.1M | $2.9B | ||
| Q1 25 | $522.3M | $2.9B | ||
| Q4 24 | $509.8M | $2.8B | ||
| Q3 24 | $542.5M | $2.8B | ||
| Q2 24 | $526.0M | $2.9B | ||
| Q1 24 | $510.9M | $2.8B |
负债/权益比
FIGS
RGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $60.9M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $58.1M | $17.6M |
| 自由现金流率自由现金流/营收 | 28.8% | 8.9% |
| 资本支出强度资本支出/营收 | 1.4% | 4.1% |
| 现金转化率经营现金流/净利润 | 3.29× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $53.0M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
FIGS
RGEN
| Q4 25 | $60.9M | $25.7M | ||
| Q3 25 | $3.4M | $48.1M | ||
| Q2 25 | $-12.4M | $28.6M | ||
| Q1 25 | $9.2M | $15.0M | ||
| Q4 24 | $30.4M | $39.2M | ||
| Q3 24 | $22.6M | $49.3M | ||
| Q2 24 | $16.5M | $42.2M | ||
| Q1 24 | $11.6M | $44.7M |
自由现金流
FIGS
RGEN
| Q4 25 | $58.1M | $17.6M | ||
| Q3 25 | $531.0K | $43.4M | ||
| Q2 25 | $-13.5M | $21.5M | ||
| Q1 25 | $7.9M | $11.4M | ||
| Q4 24 | $27.1M | $33.6M | ||
| Q3 24 | $18.4M | $42.3M | ||
| Q2 24 | $7.5M | $37.4M | ||
| Q1 24 | $11.1M | $36.4M |
自由现金流率
FIGS
RGEN
| Q4 25 | 28.8% | 8.9% | ||
| Q3 25 | 0.4% | 23.0% | ||
| Q2 25 | -8.9% | 11.8% | ||
| Q1 25 | 6.3% | 6.8% | ||
| Q4 24 | 17.8% | 19.3% | ||
| Q3 24 | 13.1% | 27.3% | ||
| Q2 24 | 5.2% | 24.3% | ||
| Q1 24 | 9.3% | 24.0% |
资本支出强度
FIGS
RGEN
| Q4 25 | 1.4% | 4.1% | ||
| Q3 25 | 1.9% | 2.5% | ||
| Q2 25 | 0.7% | 3.9% | ||
| Q1 25 | 1.0% | 2.1% | ||
| Q4 24 | 2.2% | 3.2% | ||
| Q3 24 | 3.0% | 4.5% | ||
| Q2 24 | 6.2% | 3.1% | ||
| Q1 24 | 0.4% | 5.5% |
现金转化率
FIGS
RGEN
| Q4 25 | 3.29× | 1.93× | ||
| Q3 25 | 0.39× | 3.23× | ||
| Q2 25 | -1.75× | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | 16.14× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 15.04× | 12.70× | ||
| Q1 24 | 8.10× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FIGS
| Scrubwear | $154.9M | 77% |
| Non Scrubwear Lifestyle | $47.0M | 23% |
RGEN
暂无分部数据